-
Mashup Score: 2Atlas Venture 2024 Year in Review - B. Booth - 3 hour(s) ago
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0‘Crisis Averted’ Review: What the Doctors Ordered - 3 day(s) ago
The field of public health has achieved remarkable results over the years. Covid-19 proved to be an especially tough challenge.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Third Rock-backed Trace Neuroscience Debuts with $101M, RNA Drug for ALS - TimmermanReport.com - 6 day(s) ago
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0the snake - 7 day(s) ago
Al Wilson – The snake..lyricsOn her way to work one morningDown the path along side the lakeA tender hearted woman saw a poor half frozen snakeHis pretty col…
Source: www.youtube.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Beware of Tidy Success Narratives -- in Pharma, and in Life - 7 day(s) ago
Journalists tend to celebrate deals and initiatives in part because of their inherent drama, yet this approach will inevitably skew an accurate telling of the true amount of effort required for both success and failure.
Source: www.aei.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
AlloVir has been reeling ever since a trio of phase 3 trial failures last year led the company to shed almost all of its staff. | AlloVir has been reeling after a trio of phase 3 trial failures last year led the company to shed almost all of its staff. Now, the immunotherapy biotech has found a new path forward by acquiring eye disease biotech Kalaris Therapeutics.
Source: www.fiercebiotech.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2The History Place - Great Speeches Collection: Ted Kennedy Speech - The Cause Endures - 13 day(s) ago
At The History Place, part of our Great Speeches series.
Source: www.historyplace.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 11‘Crisis Averted’ Review: What the Doctors Ordered - 16 day(s) ago
The field of public health has achieved remarkable results over the years. Covid-19 proved to be an especially tough challenge.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1‘You Bet Your Life’ Review: The Dangers of Finding a Cure - 16 day(s) ago
New medical procedures, new drugs, new vaccines—as welcome as they are—inevitably involve risk, especially in the early stages.
Source: www.wsj.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5And Just Like That: What the Viral Adoption of a Clinical AI App Means for Pharma R&D - TimmermanReport.com - 17 day(s) ago
In 2011, we were experiencing the ascension of technologies like the cloud and the smartphone. Apps had become a thing: social network apps like Instagram (the iPhone “App of the Year” in 2011) and Twitter, utility apps like Evernote and Dropbox, navigation apps like Google Maps and Waze, and game apps like Angry Birds. Yet… Read More
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet
Annual year-in-review by @LifeSciVC at @atlasventure is as always an absolutely essential watch (https://t.co/tIVcPuYVVo), and a sober appraisal of scientific excitement and challenges (see this screen shot) in biotech…. https://t.co/wFF3BBhSIU